Cargando…
Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease
BACKGROUND: The Australian Imaging and Biomarker Lifestyle (AIBL) study of aging is designed to aid the discovery of biomarkers. The current study aimed to discover differentially expressed plasma proteins that could yield a blood-based screening tool for Alzheimer’s disease. METHODS: The concentrat...
Autores principales: | Laffoon, Scott B., Doecke, James D., Roberts, Anne M., Vance, Jennifer A., Reeves, Benjamin D., Pertile, Kelly K., Rumble, Rebecca L., Fowler, Chris J., Trounson, Brett, Ames, David, Martins, Ralph, Bush, Ashley I., Masters, Colin L., Grieco, Paul A., Dratz, Edward A., Roberts, Blaine R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790928/ https://www.ncbi.nlm.nih.gov/pubmed/35081972 http://dx.doi.org/10.1186/s12953-021-00185-9 |
Ejemplares similares
-
Discovery of a Missense Mutation (Q222K) of the APOE Gene from the Australian Imaging, Biomarker and Lifestyle Study
por: Roberts, Blaine R., et al.
Publicado: (2023) -
Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer’s Disease
por: Li, Yihan, et al.
Publicado: (2022) -
A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
por: Klatt, Stephan, et al.
Publicado: (2021) -
Alzheimer’s disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology
por: Rembach, Alan, et al.
Publicado: (2015) -
Rubidium and potassium levels are altered in Alzheimer’s disease brain and blood but not in cerebrospinal fluid
por: Roberts, Blaine R., et al.
Publicado: (2016)